FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

24 results

cibinqo
(abrocitinib)
Pfizer Laboratories Div Pfizer Inc
Usage: CIBINQO is indicated for treating adults and pediatric patients aged 12 and older with refractory, moderate-to-severe atopic dermatitis not adequately controlled by other systemic treatments, including biologics, or when those therapies are inadvisable. It is not recommended for use with other JAK inhibitors or immunosuppressants.
desonide
(Desonide)
Cintex Services, LLC
Usage: Desonide Gel, 0.05% is indicated for treating mild to moderate atopic dermatitis in patients aged 3 months and older. It should be used for the shortest duration necessary to achieve results, not exceeding 4 consecutive weeks, due to potential HPA axis suppression.
dexamethasone
(Dexamethasone)
Prasco Laboratories
Usage: The drug is indicated for severe allergies, dermatologic and endocrine disorders, gastrointestinal and hematologic diseases, neurogenic conditions, neoplastic diseases, and various conditions across respiratory, ophthalmic, renal, and rheumatic diseases. It serves to manage symptoms or provide palliative care in specific cases.
dexamethasone
(dexamethasone)
Amneal Pharmaceuticals NY LLC
Usage: This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.
dexamethasone
(Dexamethasone)
Rising Pharma Holdings, Inc.
Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, collagen diseases, severe allergic states, ophthalmic and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and certain miscellaneous conditions, as well as for diagnostic testing of adrenocortical hyperfunction.
dexamethasone sodium phosphate
(Dexamethasone Sodium Phosphate)
Mylan Institutional LLC
Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.
dexamethasone sodium phosphate
(Dexamethasone Sodium Phosphate)
Amneal Pharmaceuticals LLC
Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, allergic states, gastrointestinal diseases, respiratory diseases, hematologic disorders, and certain dermatologic and ophthalmic diseases. It can be administered intravenously, intramuscularly, intra-articular, or intralesionally for acute episodes and management of chronic conditions.
dexamethasone sodium phosphate
(Dexamethasone Sodium Phosphate)
Civica, Inc.
Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.
dexamethasone sodium phosphate
(Dexamethasone Sodium Phosphate)
Somerset Therapeutics, LLC
Usage: This drug is indicated for intravenous or intramuscular use in endocrine disorders, rheumatic disorders, collagen diseases, dermatologic conditions, severe allergic states, ophthalmic diseases, gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and acute exacerbations of multiple sclerosis, among other conditions.
fluocinolone acetonide
(fluocinolone acetonide)
Padagis Israel Pharmaceuticals Ltd
Usage: Fluocinolone Acetonide Topical Oil, 0.01% is indicated for topical treatment of atopic dermatitis in adults and moderate to severe cases in pediatric patients aged 3 months and older for up to 4 weeks. Safety in children under 3 months is not established.

Medications for Atopic Dermatitis

cibinqo

desonide

dexamethasone

dexamethasone

dexamethasone

dexamethasone sodium phosphate

dexamethasone sodium phosphate

dexamethasone sodium phosphate

dexamethasone sodium phosphate

fluocinolone acetonide